<DOC>
	<DOCNO>NCT01125098</DOCNO>
	<brief_summary>Exacerbations chronic obstructive pulmonary disease ( COPD ) first cause admission Pulmonary Department Italy worldwide . Guidelines recommend treat patient hospitalized exacerbation COPD antibiotic , even role bacterial infection often uncertain effect antibiotic poor . The recommendation use antibiotic guide clinical sign symptom insufficient diagnostic accuracy , whereas serum biomarkers procalcitonin ( PRO-CT ) may guide selection COPD patient need antibiotic treatment . The main aim study investigate whether antibiotic safely stop 3 day continue 10 day accord PRO-CT-guided algorithm patient hospitalized exacerbation COPD guideline recommend 3-10 day antibiotic treatment base presence increase dyspnoea , sputum purulence . The study design assess non inferiority PRO-CT guide plan compare standard guideline recommend plan . The PRO-CT guide withhold antibiotic view experimental intervention associate less antibiotic-associated complication , eg antibiotic resistance drug-related side-effect low cost . The propose study prospective , randomise control , single-blinded intervention trial compare standard PRO-CT guide antibiotic treatment plan . Patients recruit Pulmonary Department 18 University City Hospitals Italy , start October 2006 continue December 2010 . Results expect end 2011 . The 100 patient randomised standard non PRO-CT guide antibiotic treatment plan continue antibiotic 10 day , whereas 100 patient randomise PRO-CT guide antibiotic treatment plan continue 10 day stop antibiotic day 3 depend PRO-CT level measure admission , day 1 day 2 . Serum PRO-CT measure central laboratory . Patients examined admission , discharge , 10 day , 1 , 3 6 month . A telephone interview obtain 2 , 4 5 month . The primary outcome study rate exacerbation . Secondary outcome hospital readmission , admission ICU , change FEV1 , duration hospitalization , death . The sample size estimate accord primary outcome study .</brief_summary>
	<brief_title>Comparison Serum PRO-CT Guided Treatment Recommended Antibiotic Treatment COPD</brief_title>
	<detailed_description>Patients recruit Pulmonary Department 18 University City Hospitals Italy , start October 2006 continue December 2010 . The 100 patient randomised standard non PRO-CT guide antibiotic treatment plan continue antibiotic 10 day , whereas 100 patient randomise PRO-CT-guided antibiotic treatment plan continue 10 day stop antibiotic day 3 depend PRO-CT level measure admission , day 1 day 2 . Serum PRO-CT measure central laboratory . Patients examined admission ( visit 1 ) , discharge and/or 10 day ( visit 4 ) , 1 ( visit 5 ) , 3 ( visit 6 ) 6 month ( visit 7 ) . A telephone interview obtain 2 , 4 5 month . The primary outcome study rate exacerbation . Secondary outcome hospital readmission , admission ICU , change FEV1 , duration hospitalization , death . The sample size estimate accord primary outcome study .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Male female patient give write informed consent Age : adult &gt; 18 year old COPD diagnosis accord GOLD guideline : FEV1/FVC &lt; 70 % FEV1 &lt; 80 % predict . If COPD diagnosis evident previous spirometric exam patient , new spirometry obtain within 3 day admission diagnosis COPD make follow condition true : 1 ) FEV1/FVC &lt; 70 % FEV1 &lt; 80 % predict ; 2 ) history cigarette smoking ; 3 ) exclusion bronchial asthma diagnosis . At end study ( i.e . 6 month ) new spirometric exam obtain patient confirm new diagnosis COPD make admission . Diagnosis COPD exacerbation : define acuteonset dyspnoea and/or cough associate increase purulent sputum production ( ANTHONISEN criterion ) requiring , accord guideline ( GOLD 2005 ) , treatment antibiotic require hospitalization Female subject : pregnant , lactate mother lack efficient contraception subject childbearing potential ( e.g . contraceptive method oral contraceptive , IUD , tubal ligation ) Diagnosis bronchial asthma Coexisting medical condition : unstable concomitant cardiovascular , renal , hepatic , gastrointestinal , neurological , endocrine , metabolic , muscleskeletal , neoplastic , respiratory clinically significant disease ( patient stable well control hypertension diabetes may include study ) Clinical significant laboratory abnormality indicate unstable concomitant disease Patients survival least 1 year unlikely Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>PRO-CT</keyword>
	<keyword>antibiotic</keyword>
</DOC>